Citrobacter freundii and Acinetobacter baumanii infection in a patient with neoplastic lung disease - Case report

Ann Agric Environ Med. 2021 Dec 29;28(4):724-728. doi: 10.26444/aaem/140111. Epub 2021 Jul 20.

Abstract

An 85-year-old male with a tumour in his right lung was admitted to Internal Diseases Ward to continue treatment after suffering a sudden cardiac arrest. An empiric antibiotic therapy with amoxycillin was introduced due to increased inflammation markers. Blood and sputum were collected. An abundant growth of AmpC β-lactamase-producing Citrobacter freundii was observed in culture grown from the sputum. The antibiogram showed retained sensitivity to fluoroquinolones. The therapy was modified by replacing β-lactam with ciprofloxacin. Neither clinical nor laboratory improvement were observed. Blood culture indicated sepsis of Acinetobacter baumannii etiology. The strain was suspected of producing OXA carbapenemase (CARBA test positive), KPC (-), MBL (-). Antibiogram illustrated retained sensitivity to gentamicin and colistin with complete resistance to ciprofloxacin. Another modification in treatment was implemented and ciprofloxacin was replaced with colistin.

Keywords: alert pathogen; antibiotic resistance; antibiotic therapy.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter baumannii*
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins
  • Citrobacter freundii
  • Humans
  • Lung
  • Lung Diseases*
  • Male
  • Microbial Sensitivity Tests
  • Neoplasms*
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • beta-Lactamases